Sonendo, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 09, 2022 at 04:06 pm EST
Share
Sonendo, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported revenue was USD 9.85 million compared to USD 7.89 million a year ago. Net loss was USD 15.54 million compared to USD 12.73 million a year ago. Basic loss per share from continuing operations was USD 0.47 compared to USD 10.33 a year ago.
For the nine months, revenue was USD 29.43 million compared to USD 23.31 million a year ago. Net loss was USD 46.2 million compared to USD 34.79 million a year ago. Basic loss per share from continuing operations was USD 1.61 compared to USD 28.54 a year ago.
Sonendo, Inc. is a commercial-stage medical technology company focused on saving teeth from tooth decay. The Company develops and manufactures the GentleWave System, a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The system utilizes a mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy, and advanced fluid dynamics, to debride and disinfect deep regions of the complex root canal system in a less invasive procedure that preserves tooth structure. Its Product segment includes the sales of the GentleWave System console and related accessories and instruments. The Company also offers ancillary products, such as SoundSeal and its Sonendo-branded liquid solution of ethylenediaminetetraacetic acid (EDTA). SoundSeal is a material used during the GentleWave Procedure to build and create a sealing platform on the top of the crown.
SONENDO, INC. 
